Latest news
Loading news…
Nuntius Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. London, England, United Kingdom Founded 2021 1-10 employees For Profit
Genetic medicines to cure patients with life-threatening diseases
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
7
Patents
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
- Patents granted
- 3
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $112K
Company Info
- Founded
- 2021
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 2
- HQ
- London, England, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.8
- Trend (30d)
- -0.3
- Trend (90d)
- -0.2
Key People at Nuntius Therapeutics
Co-Founder and CSO
Co-Founder and CEO
7
professional contacts at Nuntius Therapeutics
Contact execs at Nuntius Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Nuntius Therapeutics
Loading news…
FAQs about Nuntius Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.